Highest-materiality recent filing
Scientific Industries sells Genie Division for $9.6M; pro forma shows net gain
Sold Genie Division to Troemner LLC for $9.6M base plus up to $1.5M earn-out; $7.6M cash received.
Scientific Industries sells Genie Division for $9.6M plus up to $1.5M earn-out
Sold substantially all Genie Division assets (benchtop lab equipment) to Troemner, LLC for $9.6M base plus up to $1.5M earn-out.
Scientific Industries raises $1.55M through private placement of 1.55M units
Sold 1,550,000 units at $1.00 each for total gross proceeds of $1,550,000.
Scientific Industries appoints Nicholas Lavacca CFO, replacing Reginald Averilla
Nicholas Lavacca named CFO effective April 1, 2025; Reginald Averilla left to pursue other opportunities.
Scientific Industries raises $1.0M in private placement of common stock and warrants
Sold 503,536 Units (common stock and warrants) on Dec 19-20, 2023 for total consideration of $1,007,072.
Scientific Industries closes $5.28M private placement; issues units at $2.00 with warrants at $2.50
Sold 2,638,076 Units at $2.00 each for total proceeds of $5,276,152 in initial closing on Dec 13, 2023.
Non-reliance on FY2022 audited and Q1 FY2023 unaudited financials due to material misstatements.
Scientific Industries names Reginald Averilla as CFO, replacing Helena R. Santos
Appointment effective April 11, 2022; Averilla brings over 10 years of financial and accounting experience.
Scientific Industries raises $3M via PIPE; sells 549,456 shares + warrants at $5.50/share
Sold 549,456 shares of common stock and warrants for 274,727 additional shares at $5.50/share, gross proceeds $3,000,008.
Scientific Industries provides pro forma financials for $7.9M aquila biolabs acquisition
Total consideration of €6.5M ($7.9M) for all outstanding shares of aquila biolabs GmbH, a German bioprocessing company.
On May 20, 2025, the Company announced the appointment of Ms. Helena Santos as its interim CFO until a suitable candidate can be appointed by the Company’s Board of Directors.
Nicholas Lavacca, who had served as the Company’s CFO since April 18, 2025, left the Company on May 19, 2025 to pursue other opportunities.
Reginald Averilla who had served as the Company’s CFO since April 11, 2022, left the Company to pursue other opportunities.
On April 1, 2025, Scientific Industries, Inc. (the “Company”), announced that it has appointed Nicholas Lavacca as its Chief Financial Officer (“CFO”).
On April 12, 2024, the Board of Directors (the “Board”) of Scientific Industries Inc. (the “Company”) appointed Michael Blechman (i) as a Class B Director of the Company, (ii) a member of the Board’s audit committee, (iii) a member of the Board’s compensation committee, and (iv) the Chair and member of the Company’s Nominating Committee.
Effective April 4, 2024, by mutual agreement between the Company and Mr. Marcus Frampton, Mr. Frampton who had been appointed a Director of the Company in March 2019, resigned from his position as a Class B Director of the Company’s Board of Directors.
On March 4, 2024, the Board of Directors (the “Board”) of the Scientific Industries Inc. (the “Company”) appointed John Nicols (i) as a Class C Director of the Company, (ii) a member of the Board’s audit committee and (iii) a member of the Board’s compensation committee.
Scientific Industries, Inc. issued a press release announcing the retirement of Joseph G. Cremonese, a member of the Company’s Class C Board of Directors and has therefore, resigned, from the Company’s Board of Directors, effective June 13, 2023.
Effective April 11, 2022, Scientific Industries, Inc. (the “Company”), hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role
Effective April 11, 2022, Scientific Industries, Inc. (the “Company”), hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Max materiality 0.90 · Median 0.50 · Most common event other_material